Tower Research Capital (TRC)’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,427
Closed -$19K 6935
2022
Q2
$19K Sell
12,427
-13,668
-52% -$10K ﹤0.01% 3877
2022
Q1
$30K Sell
26,095
-2,508
-9% -$4.09K ﹤0.01% 3167
2021
Q4
$72K Buy
28,603
+11,996
+72% +$47.1K ﹤0.01% 2479
2021
Q3
$85K Buy
16,607
+7,936
+92% +$48.2K ﹤0.01% 2533
2021
Q2
$72K Sell
8,671
-44,263
-84% -$373K ﹤0.01% 2715
2021
Q1
$461K Buy
52,934
+38,487
+266% +$398K 0.01% 1303
2020
Q4
$157K Buy
14,447
+9,023
+166% +$111K ﹤0.01% 1934
2020
Q3
$65K Sell
5,424
-11,897
-69% -$159K ﹤0.01% 3427
2020
Q2
$278K Buy
+17,321
New +$302K 0.01% 1515
2020
Q1
Sell
-1,706
Closed -$42K 4241
2019
Q4
$42K Buy
1,706
+592
+53% +$8.79K ﹤0.01% 1452
2019
Q3
$11K Buy
+1,114
New +$14.1K ﹤0.01% 2902
2019
Q2
Sell
-246
Closed -$3K 4538
2019
Q1
$3K Sell
246
-1,454
-86% -$16.3K ﹤0.01% 3345
2018
Q4
$10K Buy
+1,700
New +$13K ﹤0.01% 2492
2018
Q3
Sell
-3,146
Closed -$43K 4420
2018
Q2
$43K Buy
+3,146
New +$49K ﹤0.01% 1935
2017
Q3
Sell
-1,165
Closed -$18K 4370
2017
Q2
$18K Buy
+1,165
New +$17.6K ﹤0.01% 1285
2017
Q1
Sell
-490
Closed -$6K 4189
2016
Q4
$6K Buy
+490
New +$5.11K ﹤0.01% 2989
2016
Q3
Sell
-200
Closed -$2K 4735
2016
Q2
$2K Buy
200
+105
+111% +$1.17K ﹤0.01% 4005
2016
Q1
$1K Sell
95
-1,769
-95% -$17.9K ﹤0.01% 3859
2015
Q4
$30K Buy
1,864
+1,664
+832% +$24.7K ﹤0.01% 894
2015
Q3
$3K Sell
200
-1,663
-89% -$33.6K ﹤0.01% 3202
2015
Q2
$45K Sell
1,863
-795
-30% -$15.3K ﹤0.01% 1456
2015
Q1
$49K Buy
+2,658
New +$54.9K 0.01% 1487
2014
Q4
Sell
-264
Closed -$7K 4923
2014
Q3
$7K Buy
+264
New +$8.21K ﹤0.01% 3096
2014
Q2
Sell
-1,800
Closed -$41K 4854
2014
Q1
$41K Buy
1,800
+758
+73% +$23K 0.01% 1246
2013
Q4
$22K Buy
1,042
+942
+942% +$27.3K ﹤0.01% 2240
2013
Q3
$4K Sell
100
-10
-9% -$339 ﹤0.01% 3843
2013
Q2
$3K Buy
+110
New +$2.83K ﹤0.01% 3351

Other funds holding EPZM